SCHEMBL5125612

SCHEMBL5125612

CC(=O)c1ccccc1-c1ccc2c(c1)C(C)(C)CC2=NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 2/20 0.47
▸ ALOX5AP P20292 1/20 0.43
▸ FEN1 P39748 1/20 0.43
▸ RARB P10826 1/20 0.40
▸ RARG P13631 1/20 0.40
▸ RXRA P19793 1/20 0.40
▸ HSD17B3 P37058 1/20 0.39
▸ PGR P06401 4/20 0.39
▸ PDK2 Q15119 3/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ TRPV1 Q8NER1 2/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ ROCK2 O75116 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125606 1.00 CHEK1 (0.47) CHEK1ALOX5APFEN1RARBRARG
SCHEMBL5125602 0.83 PGR (0.42) RARBRARGRXRAPGR
SCHEMBL5125597 0.83 PGR (0.42) RARBRARGRXRAPGR
SCHEMBL4418232 0.83 PGR (0.57) CHEK1ALOX5APFEN1RARBRARG
SCHEMBL5114381 0.82 PGR (0.48) RARBRARGRXRAPGRPDK2
SCHEMBL5114379 0.82 PGR (0.48) RARBRARGRXRAPGRPDK2
SCHEMBL5118544 0.82 PDK2 (0.46) ALOX5APFEN1RARBRARGRXRA
SCHEMBL5118537 0.82 PDK2 (0.46) ALOX5APFEN1RARBRARGRXRA
SCHEMBL5122765 0.81 TDP2 (0.53) CHEK1RARBRARGPGR
SCHEMBL5122770 0.81 TDP2 (0.53) CHEK1RARBRARGPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 — — US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR CHEK1 2116/4885ALOX5AP 965/4885FEN1 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback